ImmuPharma (LON:IMM) Trading Up 4.9% – Here’s What Happened
by Danessa Lincoln · The Markets DailyImmuPharma plc (LON:IMM – Get Free Report)’s stock price was up 4.9% on Friday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 3.67 ($0.05). Approximately 109,382,164 shares traded hands during mid-day trading, an increase of 245% from the average daily volume of 31,664,631 shares. The stock had previously closed at GBX 3.50 ($0.04).
ImmuPharma Stock Up 4.9 %
The firm’s fifty day moving average is GBX 1.40 and its 200-day moving average is GBX 1.65. The stock has a market capitalization of £15.30 million, a PE ratio of -367.30 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also
- Five stocks we like better than ImmuPharma
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Short a Stock in 5 Easy Steps
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year